Baader Bank Aktiengesellschaft Incyte Corp Transaction History

Baader Bank Aktiengesellschaft

  • $1.45 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $9,129 - $11,181
130 Added 1.49%
8,880 $641,000
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $587,825 - $735,962
8,750 New
8,750 $702,000
Q3 2022

May 04, 2023
BUY
$66.18 - $82.86 $1,985 - $2,485
30 Added 0.34%
8,780 $585,000

Others Institutions Holding INCY

# of Institutions
657
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email